Stay updated on Rilzabrutinib for CSU: H1 Resistant - Clinical Trial
Sign up to get notified when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.

Latest updates to the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page
- Check6 days agoChange DetectedThe page's revision label has updated from v3.6.6 to v3.7.0, indicating a newer release of the page template/system without altering study content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedA new revision line 'Revision: v3.6.6' was added and the previous 'Revision: v3.6.5' was removed, updating the page's revision history.SummaryDifference0.0%

- Check42 days agoChange DetectedOn 2026-08-06, the study record adds a Results Posted entry and updates the open-label extension to allow either dose B or dose C with specified follow-up weeks. Enrollment is listed as 160, and several secondary outcomes and eligibility details have been revised to reflect the new design and reporting status.SummaryDifference1%

- Check63 days agoChange DetectedResults status on the study page now shows 'Results Submitted,' replacing the previous 'No Results Posted.' The page revision has been updated to v3.6.4 from v3.6.3.SummaryDifference0.0%

- Check84 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.3, indicating a new edition of the page. This change reflects minor edits or fixes applied to the page without altering its core content.SummaryDifference0.0%

- Check99 days agoChange DetectedRecruitment status now shows 'No longer looking for participants', indicating that participant enrollment has closed, while new navigation/help items such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study' have been added. The label for Intervention/Treatment has been standardized to 'Intervention/Treatment' and the site revision tag updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

Stay in the know with updates to Rilzabrutinib for CSU: H1 Resistant - Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.